Cardiovascular Disease Archives - Endocrinology Advisor

A Scientific Statement From the AHA on CV Risk in Nonalcoholic Fatty Liver Disease

By

Jessica Nye, PhD

May 13, 2022

The American Heart Association has issued a scientific statement regarding the relationship between nonalcoholic fatty liver disease and cardiovascular risk.

Diabetes

Effect of HbA_1c on Stroke Risk Among Patients With Diabetes and Atrial Fibrillation

By

Jessica Nye, PhD

May 4, 2022

A team of investigators sought to identify the effect of glycemic control on risk for stroke among patients with atrial fibrillation.

Type 2 Diabetes

Genetic Mapping Predicts Risk of Cardiovascular Events in People With Type 2 Diabetes

By

Maria Arini Lopez, PT, DPT, CSCS, CMTPT

May 4, 2022

Researchers report findings from the ACCORD trial that evaluated the relationship of a blood pressure polygenic risk score with cardiovascular outcomes in individuals with type 2 diabetes.

Cardiovascular and Metabolic Disorders

ASPC: Clinical Practice Statement on Atherosclerotic Cardiovascular Disease Risk Assessment

By

Colby Stong

May 2, 2022

The American Society for Preventive Cardiology issued a clinical practice statement regarding risk assessment for atherosclerotic cardiovascular disease.

Clinical Charts

Dyslipidemia Drug Indications

April 28, 2022

Comparative chart of single and combination treatment options indicating which lipids can be targeted for dyslipidemias.

Diabetes

Empagliflozin for Diabetes and Cardiovascular Disease Among Patients With COPD

By

Jessica Nye, PhD

April 26, 2022

Investigators assessed the impact of treatment with empagliflozin on patients with type 2 diabetes and chronic obstructive pulmonary disease.

Cardiovascular and Metabolic Disorders

Breast Arterial Calcification May be a Marker for Atherosclerotic Cardiovascular Disease

By

Jessica Nye, PhD

April 26, 2022

A study was conducted to determine the relationship between breast arterial calcification and risk for atherosclerotic cardiovascular disease.

Diabetes

Uremic Solutes Tied With Cardiovascular Death in Diabetic Kidney Disease

By

Natasha Persaud

April 22, 2022

Investigators focused on the prognostic value of the uremic solutes asymmetric dimethylarginine, symmetric dimethylarginine, and trimethylamine-N-oxide.